Immunodepletion of Abundant Peptides for Mass Spectrometry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

In mass spectrometry, the detection of all analytes in complex samples is hindered by ionization suppression, differences in ionization potential, and the limited dynamic range of detectors, particularly in proteomics where high abundance proteins interfere with the detection of lower abundance proteins, leading to incomplete sequence coverage and incorrect protein identification.

Innovation Solution

A method involving the physical removal of highly abundant and well-ionizing peptides from samples before mass spectral analysis using immunodepletion with antibodies specific to these peptides, which are identified by cleaving proteins into peptides and ranking them by ionization potential, allowing for the selective removal of problematic peptides.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If high abundance proteins are removed by affinity depletion prior to digestion, then ionization suppression is reduced, but non-specific removal of low abundance proteins occurs

Engineering Contradiction:
Improveionization suppressionVSAvoidspecificity of protein removal
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The invention segments the protein removal process by digesting proteins into peptides first, then selectively removing specific peptides using antibodies. This allows targeted depletion of high abundance protein peptides without affecting intact low abundance proteins, resolving the non-specific removal issue while maintaining ionization suppression reduction benefits

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention performs preliminary enzymatic digestion of proteins into peptides before the depletion step. This preliminary action enables subsequent antibody-based selective removal of specific peptide sequences from high abundance proteins, preventing the non-specific removal problem that occurs with intact protein affinity depletion

Inventive Principle:
Principle #10Preliminary action

2Device complexity

If peptide masses from contaminant proteins are removed from peak lists, then database searching is simplified, but ionization suppression and detector saturation remain unresolved

Engineering Contradiction:
Improvedatabase search complexityVSAvoidionization suppression
Core Design Contradiction:
Device complexityVSObject-affected harmful factors

Solution Approach 1:

The invention performs preliminary removal of contaminant and high abundance protein peptides from the sample using antibody-based immunodepletion before mass spectrometry analysis. This physical removal prevents ionization suppression and detector saturation during data acquisition, addressing the fundamental detection problems that data processing approaches cannot resolve

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention extracts and removes problematic peptide components (contaminant and high abundance protein peptides) from the complex peptide mixture using specific antibodies. This extraction eliminates the source of ionization suppression and detector saturation, allowing better detection of low abundance protein peptides

Inventive Principle:
Principle #2Taking out (Extraction)

3Quantity of substance

If intact high abundance proteins are removed by affinity depletion, then dynamic range issues are reduced, but low abundance proteins are non-specifically depleted

Engineering Contradiction:
Improveabundance of high abundance proteinsVSAvoidspecificity of depletion
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The invention segments proteins into peptides through enzymatic digestion, then applies antibody-based depletion to specific peptide sequences. This segmentation allows selective removal of high abundance protein peptides while preserving low abundance proteins, as antibodies can be designed to target unique peptide sequences without cross-reacting with peptides from low abundance proteins

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention applies local quality by using antibodies with high specificity to target only particular peptide sequences from high abundance proteins. This ensures that depletion occurs at the specific peptide level rather than affecting all proteins globally, maintaining reliability by preventing non-specific removal of low abundance proteins

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the detection of low abundance proteins by reducing ionization suppression and improving spectral quality, enabling more accurate protein identification and detection at higher sensitivity levels, such as the femtomolar or attomolar level.

Implementation Method 1

the peptides are removed by immunodepletion

Methodology Applied
Scientific EffectImmunodepletion: Adsorption

Implementation Method 2

one or more proteins in the sample are cleaved to peptides by an enzymatic or chemical method

Methodology Applied
Scientific EffectEnzymatic digestion: Enzyme

Data Source

PatentUS8771969B2Peptide antibody depletion and its application to mass spectrometry sample preparation
Publication Date: 2014.07.08 JOHNS HOPKINS UNIVERSITY
  • US8771969B2 patent drawing
  • US8771969B2 patent drawing
  • US8771969B2 patent drawing

AI summary

The present invention relates, e.g., to a method for pre-processing a sample for mass spectral analysis, comprising cleaving proteins in the sample to peptides and immunodepleting highly abundant and/or well-ionizing and/or proteotypic peptides from the sample. Also described are methods for identifying well-ionizing peptides for use in this and other methods; analytic (diagnostic) methods using antibodies against highly ionizable peptides from a protein target of interest; and compositions, kits and devices comprising antibodies of the invention.